STAT

OCTOBER 3, 2024

In the delivery room, time is everything. When I care for a patient experiencing an obstetric emergency, a few minutes can mean the difference between life and death. A pregnant uterus receives 700 milliliters of blood per minute leading up to delivery, and the same amount can be lost each minute if a postpartum hemorrhage is not adequately treated immediately after being recognized.

Controlled Substances 363

Controlled Substances 363

PharmaVoice

OCTOBER 3, 2024

As respiratory disease season approaches, experts are concerned about vaccination rates — but the industry is churning out new solutions to help.

Vaccines 130

Vaccines 130

STAT

OCTOBER 3, 2024

Schizophrenia is a poorly understood illness, but scientists now have greater insight into one of the disorder’s hallmarks, auditory hallucinations, thanks to new research published Thursday. People with schizophrenia often “hear” voices and sounds even when there are none — up to 80% of people with the mental illness have auditory hallucinations.

317

317

The Pharmacist

OCTOBER 3, 2024

The latest workforce survey suggests a decrease in the number of qualified pharmacists and pharmacy technicians working in community pharmacy in England between 2022 and 2023. The community pharmacy workforce saw a reduction of 226 qualified pharmacists and 1,108 pharmacy technicians between 2022 and 2023, according to headcount totals recorded by the NHS England (NHSE) […] The post Latest NHSE workforce survey suggests drop in community pharmacists appeared first on The Pharmacist.

Pharmacy Technician 112

Pharmacy Technician Community Pharmacies 112

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

OCTOBER 3, 2024

From its founding days, Carequality knew that overseeing the flow of sensitive patient information in U.S. health care would be a tricky business. But the data exchange nonprofit with a staff of five probably never imagined finding itself in the middle of one of the biggest, and ugliest, antitrust fights in recent memory.  On one side is one of its biggest and most influential users: the nation’s largest electronic health records vendor, Epic Systems.

304

304

pharmaphorum

OCTOBER 3, 2024

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.

105

105

Outsourcing Pharma

OCTOBER 3, 2024

SK Groupâs contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its small molecule and peptide manufacturing muscle in South Korea.

101

101

STAT

OCTOBER 3, 2024

UnitedHealth Group is suing the Centers for Medicare and Medicaid Services, asking a judge to halt the federal agency from lowering the insurance company’s 2025 Medicare Advantage quality ratings. The health care giant alleged in the lawsuit that Medicare downgraded its Medicare Advantage star ratings, which are supposed to indicate a plan’s quality, based on “an arbitrary and capricious assessment” of its call center.

291

291

Express Pharma

OCTOBER 3, 2024

Biocon Biologics, a subsidiary of Biocon, announced the successful pricing of Biocon Biologics’ debut $ 800 million (Rs 66,763 million) senior secured Notes due 2029 at a coupon of 6.67 per cent. The Bonds will be issued by Biocon Biologics Global which is a wholly owned subsidiary of Biocon Biologics and will be backed by a strong security package.

Biosimilars 99

Biosimilars Packaging 99

STAT

OCTOBER 3, 2024

Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex , allowing the man with no limb movement to control objects using his thoughts, the brain-computer interface field looks dramatically different — both the people doing the research and the technologies they are creating.  Researchers like Leigh Hochberg and Eddie Chang and big-name startups such as Synchron and Paradromics have turned what was not too long ago an arcane academi

286

286

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

OCTOBER 3, 2024

Removal of Lilly’s in-demand drugs from the FDA’s shortage list ramps up pressure on the companies selling compounded versions.

Compounding 113

Compounding 113

STAT

OCTOBER 3, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. This week Medicare regulators released a 79-page report on a pandemic-era home hospital program that allowed approved health systems to deliver inpatient care in people’s homes.

Hospitals 261

Hospitals Inpatient 261

Outsourcing Pharma

OCTOBER 3, 2024

The proceeds of the financing will support the development of LoQus23âs lead candidate, a small molecule inhibitor that is expected to enter the clinic in 2026.

98

98

STAT

OCTOBER 3, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning. Who gave up fishing on the Cape to run another biotech company? Read on today to find out.

Drug Pricing 227

Drug Pricing Drug Development 227

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

OCTOBER 3, 2024

Proscia announces launch of Concentriq Embeddings and Proscia AI Toolkit, hoping to accelerate precision medicine R&D.

111

111

STAT

OCTOBER 3, 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. When it comes to delivering shareholder value through M&A, Ron Renaud is a biotech investor’s best friend. Over the last 10 years, all three of the companies he has helmed were sold to Big Pharma for a combined $16 billion.

210

210

Express Pharma

OCTOBER 3, 2024

Funding in the pharma and healthcare space fell 45 per cent to $189 million in September 2024 from $346 million in August 2024. However, a growth of 83 per cent was observed from the $103 million raised in September 2023. 61.8 per cent of the funding in September 2024 came from late-stage investments. This was followed by early-stage and seed-stage rounds, which accounted for 34.5 per cent and 3.7 per cent of the total funding each.

87

87

STAT

OCTOBER 3, 2024

Good day from STAT’s London outpost, with Andrew Joseph here filling in for Mr. Pharmalot. We’re taking the rate at which the sun is setting earlier and earlier as a personal affront, but guess there’s no choice but to keep grinding away, perhaps fueled by an extra cup of stimulation. Maybe some headlines can also do the trick.… Two affiliated Chinese drug manufacturers targeted by forthcoming U.S. national security legislation are working on sales of some of their op

149

149

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

OCTOBER 3, 2024

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.

101

101

Express Pharma

OCTOBER 3, 2024

Suven Life Sciences announces five presentations covering clinical and pre-clinical assets from their portfolio of new chemical entities at the upcoming Neuroscience 2024 conference, taking place from October 5 to 9, 2024, in Chicago, Illinois, USA. Neuroscience 2024, the annual meeting of the Society for Neuroscience (SfN), will bring together neuroscientists from around the globe, representing leading Pharma, Biotech and Clinical Research institutes.

Labelling 81

Labelling 81

Drug Patent Watch

OCTOBER 3, 2024

Humira, used to treat various autoimmune diseases, has become the world’s best-selling drug. AbbVie has fiercely protected its patent through a strategy known as “patent thickets,” filing over 100 additional patents related to the drug’s manufacturing process, formulation, and methods of treatment[1].

79

79

pharmaphorum

OCTOBER 3, 2024

A new report commissioned by ABPI found hospitals engaging in industry partnerships more likely to follow NICE recommendations.

Hospitals 95

Hospitals 95

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

OCTOBER 3, 2024

Phase 1 trial of IRL757 demonstrates good absorption and safety profile

112

112

Express Pharma

OCTOBER 3, 2024

The Department of Pharmaceuticals, in collaboration with its affiliated offices, autonomous bodies, public sector undertakings (PSUs), and the Pharmaceutical and Medical Devices Bureau of India (PMBI), has initiated preparations for Special Campaign 4.0. These efforts include setting targets for the campaign based on parameters established by the Department of Administrative Reforms & Public Grievances (DARPG).

71

71

Pharma Times

OCTOBER 3, 2024

Largest real-world study demonstrates significant survival advantage

110

110

Express Pharma

OCTOBER 3, 2024

The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, has introduced new regulations for medical devices aimed at aligning India’s regulatory framework with globally accepted standards. This initiative seeks to foster a regulatory environment that promotes growth and innovation in the medical device sector.

Documentation 62

Documentation 62

European Pharmaceutical Review

OCTOBER 3, 2024

Ferring Pharmaceuticals has opened a new European manufacturing site focused on supporting production for one of its gene therapies to treat non-muscle invasive bladder cancer (NMIBC). The global manufacturing hub in Kuopio, Finland will bolster supply of the drug substance of its gene therapy Adstiladrin ® (nadofaragene firadenovec-vncg). The treatment is the first and only US Food and Drug Administration (FDA)-approved intravesical non-replicating gene therapy for adults with high-risk Bacillu

59

59

Pharmafile

OCTOBER 3, 2024

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) approach based on faecal calprotectin (FC) in patients with mild-to-moderate ulcerative colitis (M2M UC). These results have been published in the Journal of Clinical Medicine.1 UC is […] The post Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative

59

59

PharmaTech

OCTOBER 3, 2024

This Behind the Headlines news roundup panel discussion on recent news items includes updates regarding sickle cell therapies (e.g,, Pfizer’s withdrawal of Oxbryta and Vertex’s choosing of Lonza as the commercial manufacturer of Casgevy); Emergent BioSolutions $400 million BARDA contract for an mpox vaccine; and the first in a generation novel schizophrenia drug, Cobenfy (xanomeline and trospium chloride).

Vaccines 52

Vaccines 52

pharmaphorum

OCTOBER 3, 2024

Learn about the collaboration between Boehringer Ingelheim and Veeva to advance One Medicine through a data partnership. Explore how Richard Young, Daniel Schwenk, and Andrea Kloeble are driving innovation in the field.

52

52

ID Stewardship

OCTOBER 3, 2024

Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 30 September 2024 I recently had the honor to give a key note speech for my alma matter, Northeastern University in Boston, MA. It took me a while to put the thoughts together and I had some support from my friend Dr. Robert Kraljevich. It seems like other people might potentially benefit from reading this and learning from my 20 years of experience in the pharmacy biz… so I put it on this webpage!

52

52

Pharma Marketing Network

OCTOBER 3, 2024

In the competitive landscape of the pharmaceutical industry, effective marketing strategies are crucial for brand success. Pharmaceutical marketing is not just about reaching healthcare professionals and patients; it involves a complex interplay of understanding market dynamics, regulatory compliance, and leveraging digital platforms. This article explores key strategies for promoting pharmaceutical brands, providing insights into understanding market dynamics, identifying target audiences, craf

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52